Cellini, Numa
 Distribuzione geografica
Continente #
EU - Europa 4.277
NA - Nord America 3.324
AS - Asia 2.348
SA - Sud America 475
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 10.509
Nazione #
US - Stati Uniti d'America 3.264
DE - Germania 2.249
SG - Singapore 1.075
CN - Cina 773
SE - Svezia 605
UA - Ucraina 422
BR - Brasile 401
FR - Francia 205
GB - Regno Unito 188
IT - Italia 148
IE - Irlanda 125
FI - Finlandia 100
IN - India 95
RU - Federazione Russa 91
ID - Indonesia 85
VN - Vietnam 85
TR - Turchia 73
JP - Giappone 31
CA - Canada 27
BD - Bangladesh 25
AR - Argentina 23
BE - Belgio 22
NL - Olanda 21
CZ - Repubblica Ceca 19
PL - Polonia 19
CI - Costa d'Avorio 18
MX - Messico 17
IQ - Iraq 15
EC - Ecuador 14
ZA - Sudafrica 13
HK - Hong Kong 12
ES - Italia 11
AT - Austria 10
LT - Lituania 10
VE - Venezuela 10
CO - Colombia 8
EG - Egitto 8
IR - Iran 8
KE - Kenya 8
PK - Pakistan 8
MA - Marocco 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
TN - Tunisia 6
UY - Uruguay 6
UZ - Uzbekistan 6
AL - Albania 5
JO - Giordania 5
AM - Armenia 4
AU - Australia 4
BG - Bulgaria 4
BO - Bolivia 4
CL - Cile 4
IL - Israele 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LU - Lussemburgo 4
DZ - Algeria 3
GA - Gabon 3
JM - Giamaica 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
AZ - Azerbaigian 2
BZ - Belize 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
MW - Malawi 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 10.502
Città #
Chandler 565
Singapore 478
Ashburn 311
Jacksonville 222
San Mateo 173
Nanjing 142
Nürnberg 136
Beijing 125
Dublin 124
Dearborn 105
Wilmington 85
Ann Arbor 82
Jakarta 79
Woodbridge 76
Boston 69
Los Angeles 67
The Dalles 65
Nanchang 64
Hefei 63
Munich 63
New York 62
Izmir 58
Bremen 54
Lawrence 53
Houston 48
Moscow 47
São Paulo 47
Fairfield 43
Marseille 43
Frankfurt am Main 39
Leawood 37
Dallas 35
Redwood City 33
Seattle 33
Milan 32
Fremont 31
Hanoi 31
Kunming 28
University Park 28
Jiaxing 27
Shenyang 25
Ho Chi Minh City 24
Brussels 22
Hebei 21
Princeton 21
Buffalo 20
Abidjan 18
Kent 18
Lancaster 18
Norwalk 18
Rome 17
Auburn Hills 16
Changsha 16
Detroit 15
Mountain View 15
Tianjin 15
Bexley 14
Hangzhou 14
Helsinki 14
Santa Clara 14
Turku 14
Tokyo 13
Redmond 12
Zhengzhou 12
Cambridge 11
Hong Kong 11
Boardman 10
Chicago 10
Düsseldorf 10
Guangzhou 10
Rio de Janeiro 10
San Francisco 10
Shanghai 10
Stockholm 10
Wroclaw 10
Brooklyn 9
Cattolica 9
Denver 9
Las Vegas 9
London 9
Mumbai 9
Santo André 9
Portsmouth 8
Amsterdam 7
Atlanta 7
Belo Horizonte 7
Changchun 7
Lanzhou 7
Ningbo 7
Simi Valley 7
Augusta 6
Campinas 6
Chennai 6
Falls Church 6
Goiânia 6
Indiana 6
Johannesburg 6
Manchester 6
Mexico City 6
Montreal 6
Totale 4.601
Nome #
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 289
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 209
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 204
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 193
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 192
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 189
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 187
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 184
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 181
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 180
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 175
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 170
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 170
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 169
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 169
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 168
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 167
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 166
Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine. 165
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 164
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 162
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 161
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 159
Phase I trial of weekly gemcitabin and concurrent radiotherapy in patients with inoperable non small cell lung cancer. 158
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 157
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 157
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 157
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 155
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 154
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 154
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 148
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 148
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 148
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 145
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 142
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 138
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 136
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 136
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 135
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 129
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 129
Chemoradiation therapy and IORT in locally advanced rectal cancer: preliminary results in 36 patients 129
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 125
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 125
Virtual simulation:fifteen years later 123
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 121
Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study 121
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 121
Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation 119
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 119
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 119
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 118
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 118
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 117
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 108
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 107
Whole liver intraoperative irradiation after partial hepatectomy produces minimal functional and pathologic lesions 105
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 102
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 99
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 98
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 97
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 93
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 86
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 85
The role of computed tomography in defining the target volume for the integrated therapy of orbital epitheliomas 84
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a phase i study. 82
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). 79
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 79
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 79
INTERMITTENT INTRATHECAL METHOTREXATE AND FRACTIONAL RADIATION (M-IMFRA) PLUS CHEMOTHERAPY IN CHILDHOOD LEUKEMIA 73
Scientific committee. multidisciplinary rectal cancer management: 2nd european rectal cancer consensus conference (eureca-cc2). 65
Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. 52
The prognostic effect of clinical staging in pancreatic adenocarcinoma 44
High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful? 40
Totale 10.562
Categoria #
all - tutte 38.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 0 0 0 0 0 32 105 18 94 42 124 26
2021/2022820 73 91 10 69 77 19 13 120 31 39 122 156
2022/20231.501 206 210 112 248 95 185 75 123 159 15 51 22
2023/2024578 28 171 13 41 14 57 25 52 5 15 100 57
2024/20251.421 45 36 96 42 164 30 25 77 258 151 258 239
2025/20261.858 523 136 204 329 568 98 0 0 0 0 0 0
Totale 10.562